These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16394307)

  • 1. Inhibiting inflammation in rheumatoid arthritis.
    Firestein GS
    N Engl J Med; 2006 Jan; 354(1):80-2. PubMed ID: 16394307
    [No Abstract]   [Full Text] [Related]  

  • 2. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.
    Barber DF; Bartolomé A; Hernandez C; Flores JM; Redondo C; Fernandez-Arias C; Camps M; Rückle T; Schwarz MK; Rodríguez S; Martinez-A C; Balomenos D; Rommel C; Carrera AC
    Nat Med; 2005 Sep; 11(9):933-5. PubMed ID: 16127435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
    Konda VR; Desai A; Darland G; Bland JS; Tripp ML
    Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Animal models of collagen disease].
    Tada Y; Nagasawa K
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2469-75. PubMed ID: 9922668
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of NO synthase inhibitors on murine collagen-induced arthritis do not support a role of NO in the protective effect of IFN-gamma.
    Vermeire K; Thielemans L; Matthys P; Billiau A
    J Leukoc Biol; 2000 Jul; 68(1):119-24. PubMed ID: 10914498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice.
    Peng XD; Wu XH; Chen LJ; Wang ZL; Hu XH; Song LF; He CM; Luo YF; Chen ZZ; Jin K; Lin HG; Li XL; Wang YS; Wei YQ
    J Pharmacol Exp Ther; 2010 Jan; 332(1):46-56. PubMed ID: 19828878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of phenethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3Kinasegamma.
    Lanni TB; Greene KL; Kolz CN; Para KS; Visnick M; Mobley JL; Dudley DT; Baginski TJ; Liimatta MB
    Bioorg Med Chem Lett; 2007 Feb; 17(3):756-60. PubMed ID: 17095227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.
    Ito K; Caramori G; Adcock IM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):1-8. PubMed ID: 17021257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taming the PI3K team to hold inflammation and cancer at bay.
    Hirsch E; Ciraolo E; Ghigo A; Costa C
    Pharmacol Ther; 2008 May; 118(2):192-205. PubMed ID: 18420279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458.
    Hannig G; Bernier SG; Hoyt JG; Doyle B; Clark E; Karp RM; Lorusso J; Westlin WF
    Arthritis Rheum; 2007 Mar; 56(3):850-60. PubMed ID: 17328059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinases as targets in rheumatoid arthritis.
    Tristano AG
    Int Immunopharmacol; 2009 Jan; 9(1):1-9. PubMed ID: 18848912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Haque S; Mirjafari H; Bruce IN
    Curr Opin Lipidol; 2008 Aug; 19(4):338-43. PubMed ID: 18607179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic diseases of the connective tissue by cytostatic agents].
    Deicher H; Fricke R; Krull P
    Cah Med; 1970 May; 11(5):399-412. PubMed ID: 5424899
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current state of treatment of rheumatoid arthritis and systemic lupus erythematosus with cytotoxic drugs].
    Dekker DL; Steĭnberg AD
    Ter Arkh; 1976; 48(11):79-88. PubMed ID: 1021897
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon beta for rheumatoid arthritis: new clothes for an old kid on the block.
    Vervoordeldonk MJ; Aalbers CJ; Tak PP
    Ann Rheum Dis; 2009 Feb; 68(2):157-8. PubMed ID: 19139202
    [No Abstract]   [Full Text] [Related]  

  • 16. Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing.
    Hirsch E; Lembo G; Montrucchio G; Rommel C; Costa C; Barberis L
    Thromb Haemost; 2006 Jan; 95(1):29-35. PubMed ID: 16543958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule protein and lipid kinase inhibitors in inflammation and specific models for their evaluation.
    Gaestel M; Kotlyarov A
    Methods Mol Biol; 2012; 795():35-44. PubMed ID: 21960213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of levamisole in the adjuvant therapy of rheumatoid arthritis and systemic lupus erythematosus].
    Gandzha IM; Sakharchuk VM; Lysenko GI; Mironova KA; Galetskaia TM
    Vrach Delo; 1981 Feb; (2):16-8. PubMed ID: 7222600
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunosuppressive drugs in systemic lupus erythematosus and rheumatoid arthritis].
    Talpaz M
    Harefuah; 1980; 98(10):468-71. PubMed ID: 7450579
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cyclosporin in the treatment of disseminated lupus erythematosus and rheumatoid arthritis].
    Miescher PA; Beris P
    Internist (Berl); 1985 Sep; 26(9):575-7. PubMed ID: 3905680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.